Specifically, we choose gene-disease pairs (a) ABO and Pancreatic carcinoma (26 pieces of evidence) and (b) GPC3 and Hepatoblastoma ((17 pieces of evidence). This evidence concerns the gene GPC3 and hepatoblastoma.